-
Alternative_name
N-[2-(4-Methylpiperazin-1-yl)-5-[3-(morpholin-4- ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide
-
Description
OICR-9429 is a small-molecule inhibitor of the WDR5-MLL interaction that effectively stops the growth of breast cancer cell lines driven by p53 gene mutation. It also stops the growth of subtype of leukemia cells having specific mutation found in about 9% of the patients with acute myeloid leukemia. WDR5 is a component of a mixed-lineage leukemia (MLL) methyltransferase complex that targets histone 3.
-
CAS Number
1801787-56-3
-
Structure Available
Yes
-
Molecular Formula
C₂₉H₃₂F₃N₅O₃
-
Molecular Weight
555.59
-
Cell Permeable
yes
-
Purity
≥98% by HPLC
-
Solubilities
DMSO (>25 mg/ml)
-
Handling
Protect from air and light
-
Tag Line
An inhibitor of the WDR5-MLL interaction
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
36 months
-
PubChem CID
91623360
-
-
SMILES
CN1CCN(CC1)C2=C(C=C(C=C2)C3=CC(=CC=C3)CN4CCOCC4)NC(=O)C5=CNC(=O)C=C5C(F)(F)F
-
InChi
InChI=1S/C29H32F3N5O3/c1-35-7-9-37(10-8-35)26-6-5-22(21-4-2-3-20(15-21)19-36-11-13-40-14-12-36)16-25(26)34-28(39)23-18-33-27(38)17-24(23)29(30,31)32/h2-6,15-18H,7-14,19H2,1H3,(H,33,38)(H,34,39)
-
InChi Key
DJOVLOYCGXNVPI-UHFFFAOYSA-N
-
-
MSDS Available
Yes